Samumed’s Candidate PF Therapy, SM04646, Found to Be Well-tolerated and Safe in Phase 1 Trial

Samumed’s Candidate PF Therapy, SM04646, Found to Be Well-tolerated and Safe in Phase 1 Trial

Samumed’s nebulized inhalation solution SM04646, a candidate therapy to treat idiopathic pulmonary fibrosis (IPF), was found to be well-tolerated and to cause no serious adverse effects in a Phase 1 trial of healthy individuals in Australia. These results support the launch of future clinical trials to test the drug’s efficacy in IPF patients. According to…

4 Factors that Impact Pulmonary Fibrosis Prevention

Pulmonary fibrosis (PF) is a respiratory disease where lung tissue becomes hardened, which eventually turns into scar tissue (a.k.a. fibrosis). Unfortunately, there aren’t any existing strategies to prevent PF, but there are a number of factors that affect your PF risk. Smoking: Like with many respiratory diseases, smoking plays a key role in…

Social Media and My IPF Story: A Public to Private Journey

In my experience, online virtual support groups are growing — allowing conversations among people living with various sensitivities or intolerances, to those diagnosed with cancer, lung diseases, etc. It’s really interesting to think of how peer support has changed in the past decade with internet use. Personally, I scroll through…

5 Questions to Ask Your Healthcare Providers If You Have Pulmonary Fibrosis

When it comes to understanding pulmonary fibrosis, asking your healthcare providers any questions you may have should always be your first option. Unlike an unknown source on the Internet or that friend of a friend who suffers from the same condition, your healthcare providers are trained and studied for years to be able to answer your questions, especially…

Your PF Community

Woman laying down reading

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.

View Forums